glp-1 cardiovascular benefits 8 of GLP‑1's Beyond Weight Loss Cardiovascular benefits of glucagon-like peptide-1

According to NICE guidance (NG28), these medications have demonstrated significant benefits in glycaemic control, with some specific agents (semaglutide, liraglutide, dulaglutide) also showing cardiovascular risk reduction in clinical trials

[DOI] [PubMed] [Google Scholar] 31.GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway

shifting eating behaviors and rising nutritional needs

doi: 10.3748/wjg.v24.i16.1748 118 CusiK

While these concerns are valid, microdosing outside of clinical guidance is not a safe or evidence-based workaround

Monitor for symptoms of over-replacement, such as anxiety, rapid heart rate, insomnia , or unintentional weight loss beyond expected tirzepatide effects